Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-18

Been out all day, only just had a chance to read the Quarterly.

Seems many were expecting more from the report & looking at the replies, the resident trolls think they’ve seen a bit of sunshine with the backdrop of the recent increase in the share price on decent volume.

Firstly as chuk & pedini89 have said, a quarterly is a report on the 3 months ending June 30. Much of the information is a copy and paste from the July 10 update, they even preface that with:

“In early July the company provided an update on the most important conditions precedent, which included the following..”

So it’s just a rehash of what was reported on July 10.

They have gone into a little more detail with the bulk sampling - 250 tonnes is a big sample!

Also of interest touched on in the recent GA interview is they are investigating the aqueous ammonia being used as a stand alone product, which in the interview Lindsay said Biocom would probably use the entire product from 1 Talus plant. Such use would require virtually no capital outlay from us as its a BOO setup from Talus. This could happen a lot quicker than most expect.

Like many I was interested in the cash burn.

Note they showed $5.1m revenue from the recent placement. This is as at June 30, tranche 2 of just under $1m was received in early July and is not included here. Also $1.7m was spent on plant property and equipment, not sure if that is part of the capex spend, however only $2m in staff & admin. So nothing new here - as expected.

To summarise, a cut & paste of recent announcements, with the cashflow statement also as expected. Not even market sensitive IMO.